Skip to main content
Clinical Trials/NCT06410547
NCT06410547CompletedNot Applicable

Using Large Language Models Such As GPT-4 to Assess Guideline Adherence in Patients With Chronic Obstructive Pulmonary Disease

Charite University, Berlin, Germany1 site in 1 country78 target enrollmentStarted: May 15, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
78
Locations
1
Primary Endpoint
Percentage of patients treated in concordance with treatment guidelines at the time of hospital discharge

Study Overview

Brief Summary

According to studies in the US and the Netherlands, 33-40% of patients with chronic conditions receive care that does not follow guideline recommendations. These findings have also been demonstrated in the management of COPD. This leads to under- or over-treatment of patients and, in the case of COPD, to exacerbations and hospitalisations. These exacerbations are a significant clinical problem, affecting patient's lung function, quality of life and mortality. They are also a burden on the healthcare system. Technological advances in artificial intelligence offer the opportunity to address these issues in COPD management. In the past year, there have been remarkable innovations in the field of natural language processing, especially through large language models such as GPT-4 from OpenAI and Bard or Gemini from Google. These models offer an opportunity to improve the implementation of evidence-based care in clinical practice.

This study is a prospective, randomised trial that will compare therapy on discharge for patients with COPD. One arm will receive no intervention, while the other arm will receive a treatment recommendation from an LLM. The study will compare the percentage of patients treated according to the guideline.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosis of COPD
  • Discharge after hospitalization

Exclusion Criteria

  • Lack of Consent

Outcomes

Primary Outcomes

Percentage of patients treated in concordance with treatment guidelines at the time of hospital discharge

Time Frame: From date of admission (which is enrollment) to the date of discharge, assessed up to one month

This primary endpoint will assess the percentage of guideline-concordant treatments in each study arm.

Adherence to treatment guidelines at the time of hospital discharge

Time Frame: From date of admission (which is enrollment) to the date of discharge, assessed up to one month

The primary endpoint will assess whether the treatment at the time of discharge is consistent with the guidelines' recommendations. This is a binary outcome measure of yes or no.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Matthias Gröschel

Principal Investigator

Charite University, Berlin, Germany

Study Sites (1)

Loading locations...

Similar Trials